Journal of the National Cancer Institute Advance Access originally published online on October 7, 2008
JNCI Journal of the National Cancer Institute 2008 100(20):1430-1431; doi:10.1093/jnci/djn374
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
NEWS |
Translational Research Going Mainstream
| The first 10% of the full text of this article appears below. |
For the past decade, a small division of the National Cancer Institute has been quietly brokering alliances between laboratory scientists and clinical researchers to streamline the process of translating new discoveries into medical practice.
In some ways, the goals of NCI's Division of Cancer Control and Population Sciences (DCCPS) run against the grain of an institution that has evolved to answer critical, but often isolated, research questions. In contrast, the DCCPS was established to cut across ideological and scientific boundaries to, in effect, break researchers out of their individual silos and force them to consider the larger implications of their work. "We heavily rely on all the basic and clinical research that NCI supports. But we see ourselves as the connector between discovery and implementation," said division director Robert
Efficacy and Effectiveness
Research Pyramid
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. R. O. Payne, P. J. Embi, and C. K. Sen Translational informatics: enabling high-throughput research paradigms Physiol Genomics, November 1, 2009; 39(3): 131 - 140. [Abstract] [Full Text] [PDF] |
||||
